Banks - Regional
Build Your Comparison
Side-by-side financial analysisStock Comparison
MRBK vs NBTB vs TRMK vs CZWI vs JPM
Revenue, margins, valuation, and 5-year total return — side by side.
Banks - Regional
Banks - Regional
Banks - Regional
Banks - Diversified
MRBK vs NBTB vs TRMK vs CZWI vs JPM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Regional | Banks - Diversified |
| Market Cap | $237M | $2.52B | $2.70B | $207M | $896.00B |
| Revenue (TTM) | $205M | $902M | $1.16B | $90M | $280.33B |
| Net Income (TTM) | $22M | $169M | $224M | $14M | $57.05B |
| Gross Margin | 54.4% | 73.6% | 64.7% | 54.7% | 60.0% |
| Operating Margin | 13.8% | 24.3% | 24.2% | 7.0% | 25.9% |
| Forward P/E | 9.7x | 11.5x | 11.8x | 11.8x | 14.4x |
| Total Debt | $178M | $327M | $1.12B | $52M | $942.38B |
| Cash & Equiv. | $10M | $185M | $668M | $119M | $343.34B |
MRBK vs NBTB vs TRMK vs CZWI vs JPM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jun 20 | Jun 26 | Return |
|---|---|---|---|
| Meridian Corporation (MRBK) | 100 | 251.7 | +151.7% |
| NBT Bancorp Inc. (NBTB) | 100 | 156.6 | +56.6% |
| Trustmark Corporati… (TRMK) | 100 | 187.2 | +87.2% |
| Citizens Community … (CZWI) | 100 | 312.8 | +212.8% |
| JPMorgan Chase & Co. (JPM) | 100 | 341.0 | +241.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: MRBK vs NBTB vs TRMK vs CZWI vs JPM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
MRBK is the #2 pick in this set and the best alternative if bank quality is your priority.
- NIM 3.4% vs JPM's 2.2%
- +57.5% vs NBTB's +18.3%
NBTB ranks third and is worth considering specifically for income & stability and growth exposure.
- Dividend streak 13 yrs, beta 0.76, yield 3.0%
- Rev growth 10.4%, EPS growth 12.5%
- Beta 0.76, yield 3.0%, current ratio 1.60x
- 3.0% yield, 13-year raise streak, vs JPM's 1.9%
TRMK is the clearest fit if your priority is growth.
- 34.8% NII/revenue growth vs CZWI's -9.4%
CZWI is the clearest fit if your priority is sleep-well-at-night.
- Lower volatility, beta 0.50, Low D/E 27.6%, current ratio 3015.31x
- Beta 0.50 vs JPM's 0.94, lower leverage
JPM carries the broadest edge in this set and is the clearest fit for long-term compounding and valuation efficiency.
- 465.8% 10Y total return vs MRBK's 158.0%
- PEG 0.81 vs CZWI's 2.32
- PEG 0.81 vs 1.46
- Efficiency ratio 0.3% vs CZWI's 0.5% (lower = leaner)
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.8% NII/revenue growth vs CZWI's -9.4% | |
| Value | PEG 0.81 vs 1.46 | |
| Quality / Margins | Efficiency ratio 0.3% vs CZWI's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.50 vs JPM's 0.94, lower leverage | |
| Dividends | 3.0% yield, 13-year raise streak, vs JPM's 1.9% | |
| Momentum (1Y) | +57.5% vs NBTB's +18.3% | |
| Efficiency (ROA) | Efficiency ratio 0.3% vs CZWI's 0.5% |
MRBK vs NBTB vs TRMK vs CZWI vs JPM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
MRBK vs NBTB vs TRMK vs CZWI vs JPM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
JPM leads in 1 of 6 categories
MRBK leads 1 • NBTB leads 1 • CZWI leads 1 • TRMK leads 0 • 2 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
JPM leads this category, winning 3 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
JPM is the larger business by revenue, generating $280.3B annually — 3112.4x CZWI's $90M. JPM is the more profitable business, keeping 20.4% of every revenue dollar as net income compared to MRBK's 10.6%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $205M | $902M | $1.2B | $90M | $280.3B |
| EBITDAEarnings before interest/tax | $29M | $241M | $323M | $9M | $81.4B |
| Net IncomeAfter-tax profit | $22M | $169M | $224M | $14M | $57.0B |
| Free Cash FlowCash after capex | $5M | $225M | $230M | $11M | $100.9B |
| Gross MarginGross profit ÷ Revenue | +54.4% | +73.6% | +64.7% | +54.7% | +60.0% |
| Operating MarginEBIT ÷ Revenue | +13.8% | +24.3% | +24.2% | +7.0% | +25.9% |
| Net MarginNet income ÷ Revenue | +10.6% | +18.8% | +19.3% | +16.0% | +20.4% |
| FCF MarginFCF ÷ Revenue | +2.6% | +24.9% | +19.8% | +12.4% | +36.0% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | +24.5% | +39.5% | +5.4% | +63.0% | +16.0% |
Valuation Metrics
MRBK leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 10.6x trailing earnings, MRBK trades at a 34% valuation discount to JPM's 16.0x P/E. Adjusting for growth (PEG ratio), JPM offers better value at 0.90x vs CZWI's 2.90x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $237M | $2.5B | $2.7B | $207M | $896.0B |
| Enterprise ValueMkt cap + debt − cash | $405M | $2.7B | $3.2B | $140M | $1.50T |
| Trailing P/EPrice ÷ TTM EPS | 10.56x | 14.47x | 12.41x | 14.70x | 16.00x |
| Forward P/EPrice ÷ next-FY EPS est. | 9.74x | 11.54x | 11.75x | 11.79x | 14.40x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.06x | 1.54x | 2.90x | 0.90x |
| EV / EBITDAEnterprise value multiple | 14.19x | 11.03x | 9.67x | 15.69x | 18.36x |
| Price / SalesMarket cap ÷ Revenue | 1.15x | 2.90x | 2.41x | 2.29x | 3.20x |
| Price / BookPrice ÷ Book value/share | 1.15x | 1.29x | 1.31x | 1.11x | 2.47x |
| Price / FCFMarket cap ÷ FCF | 10.51x | 11.49x | 11.65x | 19.90x | 8.88x |
Profitability & Efficiency
NBTB leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
JPM delivers a 15.9% return on equity — every $100 of shareholder capital generates $16 in annual profit, vs $8 for CZWI. NBTB carries lower financial leverage with a 0.17x debt-to-equity ratio, signaling a more conservative balance sheet compared to JPM's 2.60x. On the Piotroski fundamental quality scale (0–9), MRBK scores 7/9 vs JPM's 5/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +11.8% | +9.5% | +10.8% | +7.8% | +15.9% |
| ROA (TTM)Return on assets | +0.9% | +1.1% | +1.2% | +0.8% | +1.3% |
| ROICReturn on invested capital | +5.9% | +7.9% | +7.1% | +2.0% | +4.5% |
| ROCEReturn on capital employed | +2.1% | +2.4% | +3.2% | +0.6% | +8.9% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 7 | 7 | 6 | 5 |
| Debt / EquityFinancial leverage | 0.89x | 0.17x | 0.53x | 0.28x | 2.60x |
| Net DebtTotal debt minus cash | $168M | $142M | $448M | -$67M | $599.0B |
| Cash & Equiv.Liquid assets | $10M | $185M | $668M | $119M | $343.3B |
| Total DebtShort + long-term debt | $178M | $327M | $1.1B | $52M | $942.4B |
| Interest CoverageEBIT ÷ Interest expense | 0.36x | 1.05x | 0.75x | 0.16x | 0.74x |
Total Returns (Dividends Reinvested)
CZWI leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JPM five years ago would be worth $21,820 today (with dividends reinvested), compared to $14,438 for NBTB. Over the past 12 months, MRBK leads with a +57.5% total return vs NBTB's +18.3%. The 3-year compound annual growth rate (CAGR) favors CZWI at 36.4% vs NBTB's 14.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +18.2% | +17.6% | +18.7% | +24.3% | -0.5% |
| 1-Year ReturnPast 12 months | +57.5% | +18.3% | +35.5% | +52.1% | +21.8% |
| 3-Year ReturnCumulative with dividends | +120.0% | +48.5% | +115.6% | +153.7% | +138.2% |
| 5-Year ReturnCumulative with dividends | +70.7% | +44.4% | +56.8% | +69.0% | +118.2% |
| 10-Year ReturnCumulative with dividends | +158.0% | +108.5% | +127.3% | +149.0% | +465.8% |
| CAGR (3Y)Annualised 3-year return | +30.1% | +14.1% | +29.2% | +36.4% | +33.6% |
Risk & Volatility
Evenly matched — NBTB and CZWI each lead in 1 of 2 comparable metrics.
Risk & Volatility
CZWI is the less volatile stock with a 0.50 beta — it tends to amplify market swings less than JPM's 0.94 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. NBTB currently trades 99.8% from its 52-week high vs MRBK's 92.1% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.65x | 0.76x | 0.82x | 0.50x | 0.94x |
| 52-Week HighHighest price in past year | $21.67 | $48.27 | $46.03 | $22.62 | $337.25 |
| 52-Week LowLowest price in past year | $11.16 | $39.20 | $33.39 | $12.83 | $262.71 |
| % of 52W HighCurrent price vs 52-week peak | +92.1% | +99.8% | +99.7% | +94.9% | +95.1% |
| RSI (14)Momentum oscillator 0–100 | 70.2 | 63.1 | 60.1 | 51.2 | 59.1 |
| Avg Volume (50D)Average daily shares traded | 117K | 266K | 330K | 41K | 7.0M |
Analyst Outlook
Evenly matched — NBTB and JPM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: MRBK as "Buy", NBTB as "Hold", TRMK as "Hold", CZWI as "Buy", JPM as "Buy". Consensus price targets imply 5.9% upside for JPM (target: $340) vs -4.5% for NBTB (target: $46). For income investors, NBTB offers the higher dividend yield at 2.96% vs CZWI's 1.73%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Hold | Hold | Buy | Buy |
| Price TargetConsensus 12-month target | $21.00 | $46.00 | $45.50 | — | $339.75 |
| # AnalystsCovering analysts | 4 | 10 | 9 | 2 | 61 |
| Dividend YieldAnnual dividend ÷ price | +2.5% | +3.0% | +2.1% | +1.7% | +1.9% |
| Dividend StreakConsecutive years of raises | 0 | 13 | 1 | 6 | 15 |
| Dividend / ShareAnnual DPS | $0.49 | $1.43 | $0.97 | $0.37 | $5.95 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.2% | +0.4% | +3.0% | +3.0% | +3.9% |
JPM leads in 1 of 6 categories (Income & Cash Flow). MRBK leads in 1 (Valuation Metrics). 2 tied.
MRBK vs NBTB vs TRMK vs CZWI vs JPM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is MRBK or NBTB or TRMK or CZWI or JPM a better buy right now?
For growth investors, Trustmark Corporation (TRMK) is the stronger pick with 34.
8% revenue growth year-over-year, versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). Meridian Corporation (MRBK) offers the better valuation at 10. 6x trailing P/E (9. 7x forward), making it the more compelling value choice. Analysts rate Meridian Corporation (MRBK) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — MRBK or NBTB or TRMK or CZWI or JPM?
On trailing P/E, Meridian Corporation (MRBK) is the cheapest at 10.
6x versus JPMorgan Chase & Co. at 16. 0x. On forward P/E, Meridian Corporation is actually cheaper at 9. 7x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: JPMorgan Chase & Co. wins at 0. 81x versus Citizens Community Bancorp, Inc. 's 2. 32x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — MRBK or NBTB or TRMK or CZWI or JPM?
Over the past 5 years, JPMorgan Chase & Co.
(JPM) delivered a total return of +118. 2%, compared to +44. 4% for NBT Bancorp Inc. (NBTB). Over 10 years, the gap is even starker: JPM returned +465. 8% versus NBTB's +108. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — MRBK or NBTB or TRMK or CZWI or JPM?
By beta (market sensitivity over 5 years), Citizens Community Bancorp, Inc.
(CZWI) is the lower-risk stock at 0. 50β versus JPMorgan Chase & Co. 's 0. 94β — meaning JPM is approximately 90% more volatile than CZWI relative to the S&P 500. On balance sheet safety, NBT Bancorp Inc. (NBTB) carries a lower debt/equity ratio of 17% versus 3% for JPMorgan Chase & Co. — giving it more financial flexibility in a downturn.
05Which is growing faster — MRBK or NBTB or TRMK or CZWI or JPM?
By revenue growth (latest reported year), Trustmark Corporation (TRMK) is pulling ahead at 34.
8% versus -9. 4% for Citizens Community Bancorp, Inc. (CZWI). On earnings-per-share growth, the picture is similar: Meridian Corporation grew EPS 30. 3% year-over-year, compared to 1. 5% for JPMorgan Chase & Co.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — MRBK or NBTB or TRMK or CZWI or JPM?
JPMorgan Chase & Co.
(JPM) is the more profitable company, earning 20. 4% net margin versus 10. 6% for Meridian Corporation — meaning it keeps 20. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: JPM leads at 26. 0% versus 7. 0% for CZWI. At the gross margin level — before operating expenses — NBTB leads at 72. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is MRBK or NBTB or TRMK or CZWI or JPM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, JPMorgan Chase & Co. (JPM) is the more undervalued stock at a PEG of 0. 81x versus Citizens Community Bancorp, Inc. 's 2. 32x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Meridian Corporation (MRBK) trades at 9. 7x forward P/E versus 14. 4x for JPMorgan Chase & Co. — 4. 7x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for JPM: 5. 9% to $339. 75.
08Which pays a better dividend — MRBK or NBTB or TRMK or CZWI or JPM?
All stocks in this comparison pay dividends.
NBT Bancorp Inc. (NBTB) offers the highest yield at 3. 0%, versus 1. 7% for Citizens Community Bancorp, Inc. (CZWI).
09Is MRBK or NBTB or TRMK or CZWI or JPM better for a retirement portfolio?
For long-horizon retirement investors, Citizens Community Bancorp, Inc.
(CZWI) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 50), 1. 7% yield, +149. 0% 10Y return). Both have compounded well over 10 years (CZWI: +149. 0%, TRMK: +127. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between MRBK and NBTB and TRMK and CZWI and JPM?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: MRBK is a small-cap deep-value stock; NBTB is a small-cap deep-value stock; TRMK is a small-cap high-growth stock; CZWI is a small-cap deep-value stock; JPM is a large-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.